{"data":{"matter":{"matter_id":"mat_ead13a2aadc579","slug":"tepezza-hearing-loss","name":"Tepezza Hearing Loss","category":"mass_tort","subcategory":"pharma","status":"litigated","score":0.6,"score_30d":0.2116,"velocity":0.5752,"headline":"Tepezza hearing loss - MDL alleges the thyroid-eye-disease drug causes permanent hearing damage","summary":"Tepezza (teprotumumab), a Horizon Therapeutics infusion drug for thyroid eye disease, is alleged to cause permanent hearing loss and tinnitus that the label failed to adequately warn about. The federal cases are consolidated in an MDL in the Northern District of Illinois. Eligibility centers on having been treated with Tepezza infusions and later developing hearing loss or tinnitus.","eligibility_hint":"Were treated with Tepezza infusions and developed hearing loss or tinnitus","payout":{"band":"mass_tort","low_cents":5000000,"high_cents":100000000,"low_usd":50000,"high_usd":1000000},"keywords":{"products":["tepezza","teprotumumab","thyroid eye disease","hearing loss","tinnitus"],"brands":["horizon therapeutics","amgen"]},"links":{"primary":"https://www.ilnd.uscourts.gov/","self":"https://www.getclaimscout.com/api/v1/matters/tepezza-hearing-loss","html":"https://www.getclaimscout.com/matters/tepezza-hearing-loss","lp":null},"lifecycle":{"first_seen_iso":"2026-07-07T10:06:26Z","last_signal_iso":"2026-07-16T08:12:19Z","mdl_filed_iso":null,"settlement_announced_iso":null,"claims_open_iso":null,"claims_close_iso":null,"narrative_generated_iso":"2026-07-07T10:06:26Z"},"attached_cases_count":0,"embedding_model":null,"embedding_version":1,"schema_version":1},"attached_cases":[],"recent_signals":[{"signal_id":"sig_d0b92b927f9125","matter_id":"mat_ead13a2aadc579","source":"google_news","source_id":"gnews:CBMihwFBVV95cUxOeDBuYUE4eTVCSzBhOHBxQy1SR3pLX25najBJSUJMbkZoNUNkMmp4eTd5S3FPcHhlc2NSZVZIQ0J5TW1oWFZsZ19aNVktUUhkRFg4R1BwRGxFSzk3bkUyTHBLRlVsWk9CZmtIcUNGYk9vRjNBcThVT3NUNi1JRTRLSmxuUUlob2M","kind":"news_article","title":"Horizon Therapeutics Faces Tepezza Lawsuits for Hearing Loss, Tinnitus - Drugwatch.com","summary":"Horizon Therapeutics Faces Tepezza Lawsuits for Hearing Loss, Tinnitus    Drugwatch.com","url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxOeDBuYUE4eTVCSzBhOHBxQy1SR3pLX25najBJSUJMbkZoNUNkMmp4eTd5S3FPcHhlc2NSZVZIQ0J5TW1oWFZsZ19aNVktUUhkRFg4R1BwRGxFSzk3bkUyTHBLRlVsWk9CZmtIcUNGYk9vRjNBcThVT3NUNi1JRTRLSmxuUUlob2M?oc=5","score":0.55,"decayed_score":null,"keywords":{"brands":["horizon therapeutics","amgen"],"products":["tepezza","teprotumumab","thyroid eye disease","hearing loss","tinnitus"]},"provenance":{"feed":"google_news_rss","published":"Mon, 14 Nov 2022 08:00:00 GMT","source_url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxOeDBuYUE4eTVCSzBhOHBxQy1SR3pLX25najBJSUJMbkZoNUNkMmp4eTd5S3FPcHhlc2NSZVZIQ0J5TW1oWFZsZ19aNVktUUhkRFg4R1BwRGxFSzk3bkUyTHBLRlVsWk9CZmtIcUNGYk9vRjNBcThVT3NUNi1JRTRLSmxuUUlob2M?oc=5","retrieved_at":"2026-07-16T08:12:19Z","search_query":"\"tepezza\" (lawsuit OR settlement OR recall OR \"class action\")"},"resolved_by":"auto","resolution_confidence":0.625,"first_seen_iso":"2026-07-16T08:12:19Z","last_seen_iso":"2026-07-16T08:12:19Z","schema_version":1},{"signal_id":"sig_30bb11cb1f7a68","matter_id":"mat_ead13a2aadc579","source":"google_news","source_id":"gnews:CBMilAFBVV95cUxNNVdVZHVRank0WlhoNENfa2lyR2VMekZ4bUtVY2F5LUJVUlp2b2RfeGR0elBvRG9qamRkLVQ3TXBKT0IwQTdLZWladnBHekdEWmt2UDc2WThqV1poOG1HOGt4TGdKeGllTVdkQmxRSm9UREN5UnRlQ3docDZQX1ZzcVBoTktlUlNUNnlCcXNsbUJCLXc5","kind":"news_article","title":"FDA adds new warning to Tepezza label - Eyes On Eyecare","summary":"FDA adds new warning to Tepezza label    Eyes On Eyecare","url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNNVdVZHVRank0WlhoNENfa2lyR2VMekZ4bUtVY2F5LUJVUlp2b2RfeGR0elBvRG9qamRkLVQ3TXBKT0IwQTdLZWladnBHekdEWmt2UDc2WThqV1poOG1HOGt4TGdKeGllTVdkQmxRSm9UREN5UnRlQ3docDZQX1ZzcVBoTktlUlNUNnlCcXNsbUJCLXc5?oc=5","score":0.55,"decayed_score":null,"keywords":{"brands":["horizon therapeutics","amgen"],"products":["tepezza","teprotumumab","thyroid eye disease","hearing loss","tinnitus"]},"provenance":{"feed":"google_news_rss","published":"Wed, 26 Jul 2023 07:00:00 GMT","source_url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNNVdVZHVRank0WlhoNENfa2lyR2VMekZ4bUtVY2F5LUJVUlp2b2RfeGR0elBvRG9qamRkLVQ3TXBKT0IwQTdLZWladnBHekdEWmt2UDc2WThqV1poOG1HOGt4TGdKeGllTVdkQmxRSm9UREN5UnRlQ3docDZQX1ZzcVBoTktlUlNUNnlCcXNsbUJCLXc5?oc=5","retrieved_at":"2026-07-16T08:12:19Z","search_query":"\"tepezza\" (lawsuit OR settlement OR recall OR \"class action\")"},"resolved_by":"auto","resolution_confidence":1.0,"first_seen_iso":"2026-07-14T08:03:27Z","last_seen_iso":"2026-07-16T08:12:19Z","schema_version":1},{"signal_id":"sig_6786263878078f","matter_id":"mat_ead13a2aadc579","source":"courtlistener_search","source_id":"cl-search:71938758","kind":"court_filing","title":"CL filing: IN RE: Air Crash at Muan International Airport, South Korea on December 29, 2024","summary":"Federal filing in jpml, docket MDL No. 3174, dated 2025-11-19.","url":"https://www.courtlistener.com/recap/?q=tepezza","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"jpml","docket_no":"MDL No. 3174","date_filed":"2025-11-19","source_url":"https://www.courtlistener.com/recap/?q=tepezza","retrieved_at":"2026-07-16T08:21:58Z","search_query":"tepezza"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-07-08T08:36:58Z","last_seen_iso":"2026-07-16T08:21:58Z","schema_version":1},{"signal_id":"sig_b8eb55a98882e6","matter_id":"mat_ead13a2aadc579","source":"courtlistener_search","source_id":"cl-search:71566029","kind":"court_filing","title":"CL filing: IN RE: Trans Union, LLC, Customer Data Security Breach Litigation","summary":"Federal filing in jpml, docket MDL No. 3170, dated 2025-10-03.","url":"https://www.courtlistener.com/recap/?q=tepezza","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"jpml","docket_no":"MDL No. 3170","date_filed":"2025-10-03","source_url":"https://www.courtlistener.com/recap/?q=tepezza","retrieved_at":"2026-07-16T08:21:58Z","search_query":"tepezza"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-07-08T08:36:58Z","last_seen_iso":"2026-07-16T08:21:58Z","schema_version":1},{"signal_id":"sig_abee903cb7ac6c","matter_id":"mat_ead13a2aadc579","source":"courtlistener_search","source_id":"cl-search:71459598","kind":"court_filing","title":"CL filing: In re: Boyd Gaming Corp. Breach Litigation","summary":"Federal filing in nvd, docket 2:25-cv-01814, dated 2025-09-25.","url":"https://www.courtlistener.com/recap/?q=tepezza","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"nvd","docket_no":"2:25-cv-01814","date_filed":"2025-09-25","source_url":"https://www.courtlistener.com/recap/?q=tepezza","retrieved_at":"2026-07-16T08:21:58Z","search_query":"tepezza"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-07-08T08:36:58Z","last_seen_iso":"2026-07-16T08:21:58Z","schema_version":1},{"signal_id":"sig_aedc51371bc27c","matter_id":"mat_ead13a2aadc579","source":"courtlistener_search","source_id":"cl-search:71180992","kind":"court_filing","title":"CL filing: IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Non-Arteritic Anterior Ischemic Optic Neuropathy Products Liability Litigation","summary":"Federal filing in jpml, docket MDL No. 3163, dated 2025-08-19.","url":"https://www.courtlistener.com/recap/?q=tepezza","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"jpml","docket_no":"MDL No. 3163","date_filed":"2025-08-19","source_url":"https://www.courtlistener.com/recap/?q=tepezza","retrieved_at":"2026-07-16T08:21:58Z","search_query":"tepezza"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-07-08T08:36:58Z","last_seen_iso":"2026-07-16T08:21:58Z","schema_version":1},{"signal_id":"sig_e3d10ef4b1129f","matter_id":"mat_ead13a2aadc579","source":"courtlistener_search","source_id":"cl-search:73371682","kind":"court_filing","title":"CL filing: CAPRICOR THERAPEUTICS, INC. v. NIPPON SHINYAKU CO., LTD.","summary":"Federal filing in njd, docket 2:26-cv-05788, dated 2026-05-20.","url":"https://www.courtlistener.com/recap/?q=tepezza","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"njd","docket_no":"2:26-cv-05788","date_filed":"2026-05-20","source_url":"https://www.courtlistener.com/recap/?q=tepezza","retrieved_at":"2026-07-16T08:21:58Z","search_query":"tepezza"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-07-08T08:36:57Z","last_seen_iso":"2026-07-16T08:21:58Z","schema_version":1},{"signal_id":"sig_f03e0786b0562b","matter_id":"mat_ead13a2aadc579","source":"courtlistener_search","source_id":"cl-search:72533633","kind":"court_filing","title":"CL filing: IN RE: Nitrogen, Phosphorus, and Potassium (NPK) Fertilizer Antitrust Litigation","summary":"Federal filing in jpml, docket MDL No. 3187, dated 2026-03-19.","url":"https://www.courtlistener.com/recap/?q=tepezza","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"jpml","docket_no":"MDL No. 3187","date_filed":"2026-03-19","source_url":"https://www.courtlistener.com/recap/?q=tepezza","retrieved_at":"2026-07-16T08:21:58Z","search_query":"tepezza"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-07-08T08:36:57Z","last_seen_iso":"2026-07-16T08:21:58Z","schema_version":1},{"signal_id":"sig_ed3b5573163c92","matter_id":"mat_ead13a2aadc579","source":"courtlistener_search","source_id":"cl-search:72284647","kind":"court_filing","title":"CL filing: Plumbers' Welfare Fund, Local 130 U.A. v. Express Scripts, Inc.","summary":"Federal filing in ilnd, docket 1:26-cv-01718, dated 2026-02-17.","url":"https://www.courtlistener.com/recap/?q=tepezza","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"ilnd","docket_no":"1:26-cv-01718","date_filed":"2026-02-17","source_url":"https://www.courtlistener.com/recap/?q=tepezza","retrieved_at":"2026-07-16T08:21:58Z","search_query":"tepezza"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-07-08T08:36:57Z","last_seen_iso":"2026-07-16T08:21:58Z","schema_version":1},{"signal_id":"sig_fc4535d0494064","matter_id":"mat_ead13a2aadc579","source":"courtlistener_search","source_id":"cl-search:72153472","kind":"court_filing","title":"CL filing: Sagebrush Health Services v. Amgen Inc.","summary":"Federal filing in cacd, docket 2:26-cv-00466, dated 2026-01-16.","url":"https://www.courtlistener.com/recap/?q=tepezza","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"cacd","docket_no":"2:26-cv-00466","date_filed":"2026-01-16","source_url":"https://www.courtlistener.com/recap/?q=tepezza","retrieved_at":"2026-07-16T08:21:58Z","search_query":"tepezza"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-07-08T08:36:57Z","last_seen_iso":"2026-07-16T08:21:58Z","schema_version":1},{"signal_id":"sig_f973cd61c98776","matter_id":"mat_ead13a2aadc579","source":"fda_faers","source_id":"faers:26549084","kind":"adverse_event_report","title":"FAERS: tepezza - Thyrotoxic crisis","summary":"FDA Adverse Event Report ID 26549084. Reactions: Thyrotoxic crisis. Outcome flagged as: death / life-threatening / hospitalization / disabling.","url":"https://open.fda.gov/data/faers/?search=safetyreportid:26549084","score":0.85,"decayed_score":null,"keywords":{"brands":["horizon therapeutics","amgen"],"products":["tepezza","teprotumumab","thyroid eye disease","hearing loss","tinnitus"]},"provenance":{"feed":"fda_openfda_faers","outcome":"death / life-threatening / hospitalization / disabling","reactions":["Thyrotoxic crisis"],"drug_query":"tepezza","source_url":"https://open.fda.gov/data/faers/?search=safetyreportid:26549084","receivedate":"20260329","retrieved_at":"2026-07-16T08:14:03Z","safetyreportid":"26549084"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-07-08T08:28:53Z","last_seen_iso":"2026-07-16T08:14:03Z","schema_version":1},{"signal_id":"sig_fcf2ef80548342","matter_id":"mat_ead13a2aadc579","source":"fda_faers","source_id":"faers:26548220","kind":"adverse_event_report","title":"FAERS: tepezza - Death","summary":"FDA Adverse Event Report ID 26548220. Reactions: Death. Outcome flagged as: death / life-threatening / hospitalization / disabling.","url":"https://open.fda.gov/data/faers/?search=safetyreportid:26548220","score":0.85,"decayed_score":null,"keywords":{"brands":["horizon therapeutics","amgen"],"products":["tepezza","teprotumumab","thyroid eye disease","hearing loss","tinnitus"]},"provenance":{"feed":"fda_openfda_faers","outcome":"death / life-threatening / hospitalization / disabling","reactions":["Death"],"drug_query":"tepezza","source_url":"https://open.fda.gov/data/faers/?search=safetyreportid:26548220","receivedate":"20260328","retrieved_at":"2026-07-16T08:14:03Z","safetyreportid":"26548220"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-07-08T08:28:53Z","last_seen_iso":"2026-07-16T08:14:03Z","schema_version":1},{"signal_id":"sig_e461f5e008318e","matter_id":"mat_ead13a2aadc579","source":"fda_faers","source_id":"faers:26546779","kind":"adverse_event_report","title":"FAERS: tepezza - Endocrine ophthalmopathy, Radiotherapy, Off label use, Madarosis","summary":"FDA Adverse Event Report ID 26546779. Reactions: Endocrine ophthalmopathy, Radiotherapy, Off label use, Madarosis. Outcome flagged as: death / life-threatening / hospitalization / disabling.","url":"https://open.fda.gov/data/faers/?search=safetyreportid:26546779","score":0.85,"decayed_score":null,"keywords":{"brands":["horizon therapeutics","amgen"],"products":["tepezza","teprotumumab","thyroid eye disease","hearing loss","tinnitus"]},"provenance":{"feed":"fda_openfda_faers","outcome":"death / life-threatening / hospitalization / disabling","reactions":["Endocrine ophthalmopathy","Radiotherapy","Off label use","Madarosis"],"drug_query":"tepezza","source_url":"https://open.fda.gov/data/faers/?search=safetyreportid:26546779","receivedate":"20260328","retrieved_at":"2026-07-16T08:14:03Z","safetyreportid":"26546779"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-07-08T08:28:53Z","last_seen_iso":"2026-07-16T08:14:03Z","schema_version":1},{"signal_id":"sig_98daec9534ceef","matter_id":"mat_ead13a2aadc579","source":"fda_faers","source_id":"faers:26549087","kind":"adverse_event_report","title":"FAERS: tepezza - Crohn^s disease","summary":"FDA Adverse Event Report ID 26549087. Reactions: Crohn^s disease. Outcome flagged as: death / life-threatening / hospitalization / disabling.","url":"https://open.fda.gov/data/faers/?search=safetyreportid:26549087","score":0.85,"decayed_score":null,"keywords":{"brands":["horizon therapeutics","amgen"],"products":["tepezza","teprotumumab","thyroid eye disease","hearing loss","tinnitus"]},"provenance":{"feed":"fda_openfda_faers","outcome":"death / life-threatening / hospitalization / disabling","reactions":["Crohn^s disease"],"drug_query":"tepezza","source_url":"https://open.fda.gov/data/faers/?search=safetyreportid:26549087","receivedate":"20260329","retrieved_at":"2026-07-16T08:14:03Z","safetyreportid":"26549087"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-07-08T08:28:53Z","last_seen_iso":"2026-07-16T08:14:03Z","schema_version":1},{"signal_id":"sig_9bf1646e22922d","matter_id":"mat_ead13a2aadc579","source":"fda_faers","source_id":"faers:26555710","kind":"adverse_event_report","title":"FAERS: tepezza - Optic ischaemic neuropathy, Optic disc disorder","summary":"FDA Adverse Event Report ID 26555710. Reactions: Optic ischaemic neuropathy, Optic disc disorder. Outcome flagged as: death / life-threatening / hospitalization / disabling.","url":"https://open.fda.gov/data/faers/?search=safetyreportid:26555710","score":0.85,"decayed_score":null,"keywords":{"brands":["horizon therapeutics","amgen"],"products":["tepezza","teprotumumab","thyroid eye disease","hearing loss","tinnitus"]},"provenance":{"feed":"fda_openfda_faers","outcome":"death / life-threatening / hospitalization / disabling","reactions":["Optic ischaemic neuropathy","Optic disc disorder"],"drug_query":"tepezza","source_url":"https://open.fda.gov/data/faers/?search=safetyreportid:26555710","receivedate":"20260331","retrieved_at":"2026-07-16T08:14:03Z","safetyreportid":"26555710"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-07-08T08:28:52Z","last_seen_iso":"2026-07-16T08:14:03Z","schema_version":1},{"signal_id":"sig_35d382f01b604e","matter_id":"mat_ead13a2aadc579","source":"fda_faers","source_id":"faers:26555080","kind":"adverse_event_report","title":"FAERS: tepezza - Dizziness, Throat irritation","summary":"FDA Adverse Event Report ID 26555080. Reactions: Dizziness, Throat irritation. Outcome flagged as: death / life-threatening / hospitalization / disabling.","url":"https://open.fda.gov/data/faers/?search=safetyreportid:26555080","score":0.85,"decayed_score":null,"keywords":{"brands":["horizon therapeutics","amgen"],"products":["tepezza","teprotumumab","thyroid eye disease","hearing loss","tinnitus"]},"provenance":{"feed":"fda_openfda_faers","outcome":"death / life-threatening / hospitalization / disabling","reactions":["Dizziness","Throat irritation"],"drug_query":"tepezza","source_url":"https://open.fda.gov/data/faers/?search=safetyreportid:26555080","receivedate":"20260330","retrieved_at":"2026-07-16T08:14:03Z","safetyreportid":"26555080"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-07-08T08:28:52Z","last_seen_iso":"2026-07-16T08:14:03Z","schema_version":1},{"signal_id":"sig_55feca055253b0","matter_id":"mat_ead13a2aadc579","source":"fda_faers","source_id":"faers:26561413","kind":"adverse_event_report","title":"FAERS: tepezza - Death, Off label use","summary":"FDA Adverse Event Report ID 26561413. Reactions: Death, Off label use. Outcome flagged as: death / life-threatening / hospitalization / disabling.","url":"https://open.fda.gov/data/faers/?search=safetyreportid:26561413","score":0.85,"decayed_score":null,"keywords":{"brands":["horizon therapeutics","amgen"],"products":["tepezza","teprotumumab","thyroid eye disease","hearing loss","tinnitus"]},"provenance":{"feed":"fda_openfda_faers","outcome":"death / life-threatening / hospitalization / disabling","reactions":["Death","Off label use"],"drug_query":"tepezza","source_url":"https://open.fda.gov/data/faers/?search=safetyreportid:26561413","receivedate":"20260331","retrieved_at":"2026-07-16T08:14:03Z","safetyreportid":"26561413"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-07-08T08:28:52Z","last_seen_iso":"2026-07-16T08:14:03Z","schema_version":1},{"signal_id":"sig_993e9017657078","matter_id":"mat_ead13a2aadc579","source":"fda_faers","source_id":"faers:26555043","kind":"adverse_event_report","title":"FAERS: tepezza - Influenza, Pneumonia","summary":"FDA Adverse Event Report ID 26555043. Reactions: Influenza, Pneumonia. Outcome flagged as: death / life-threatening / hospitalization / disabling.","url":"https://open.fda.gov/data/faers/?search=safetyreportid:26555043","score":0.85,"decayed_score":null,"keywords":{"brands":["horizon therapeutics","amgen"],"products":["tepezza","teprotumumab","thyroid eye disease","hearing loss","tinnitus"]},"provenance":{"feed":"fda_openfda_faers","outcome":"death / life-threatening / hospitalization / disabling","reactions":["Influenza","Pneumonia"],"drug_query":"tepezza","source_url":"https://open.fda.gov/data/faers/?search=safetyreportid:26555043","receivedate":"20260330","retrieved_at":"2026-07-16T08:14:03Z","safetyreportid":"26555043"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-07-08T08:28:52Z","last_seen_iso":"2026-07-16T08:14:03Z","schema_version":1},{"signal_id":"sig_a7a7e0f2381627","matter_id":"mat_ead13a2aadc579","source":"google_news","source_id":"gnews:CBMiogFBVV95cUxPZE1nNVFSaXQ5cmo0WThUMnVTY2VUT1lLSS14cnlWWUJXaGZZWElBajJBNEU4QUlvVWlOV0htWlYzWUN5cUlIYk1mOGNoWmwyNXFleEY1aGMtcWxSWkhzTWNTYWJGWjQ3VUVLbURuaVRqZ2liX3ktVlZvTUZQTncxdDQ5V2NHUnhKTDJSTTBuVXI1cjRzZU9BV0UxR1VXRk9jZ3c","kind":"news_article","title":"Tepezza Bellwether Deadlines Stricken, Raising Speculation of Hearing Loss Settlement - AboutLawsuits.com","summary":"Tepezza Bellwether Deadlines Stricken, Raising Speculation of Hearing Loss Settlement    AboutLawsuits.com","url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPZE1nNVFSaXQ5cmo0WThUMnVTY2VUT1lLSS14cnlWWUJXaGZZWElBajJBNEU4QUlvVWlOV0htWlYzWUN5cUlIYk1mOGNoWmwyNXFleEY1aGMtcWxSWkhzTWNTYWJGWjQ3VUVLbURuaVRqZ2liX3ktVlZvTUZQTncxdDQ5V2NHUnhKTDJSTTBuVXI1cjRzZU9BV0UxR1VXRk9jZ3c?oc=5","score":0.55,"decayed_score":null,"keywords":{"brands":["horizon therapeutics","amgen"],"products":["tepezza","teprotumumab","thyroid eye disease","hearing loss","tinnitus"]},"provenance":{"feed":"google_news_rss","published":"Tue, 14 Oct 2025 07:00:00 GMT","source_url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPZE1nNVFSaXQ5cmo0WThUMnVTY2VUT1lLSS14cnlWWUJXaGZZWElBajJBNEU4QUlvVWlOV0htWlYzWUN5cUlIYk1mOGNoWmwyNXFleEY1aGMtcWxSWkhzTWNTYWJGWjQ3VUVLbURuaVRqZ2liX3ktVlZvTUZQTncxdDQ5V2NHUnhKTDJSTTBuVXI1cjRzZU9BV0UxR1VXRk9jZ3c?oc=5","retrieved_at":"2026-07-16T08:12:19Z","search_query":"\"tepezza\" (lawsuit OR settlement OR recall OR \"class action\")"},"resolved_by":"auto","resolution_confidence":1.0,"first_seen_iso":"2026-07-08T08:27:04Z","last_seen_iso":"2026-07-16T08:12:19Z","schema_version":1},{"signal_id":"sig_bb719190d38408","matter_id":"mat_ead13a2aadc579","source":"google_news","source_id":"gnews:CBMiVkFVX3lxTE5QYW1WRWFxUmRja0c3aS1NUzh0ai1STm8yN09DbzR3UmUyTlBHYi1pelZJa0k2QnhXeGlXMjFNa0MxQjZmV2lIUHprMzZ4R2NseWRqa1R3","kind":"news_article","title":"Tepezza Lawsuit Update 2026: Payouts, News, Trials - LawFold.com","summary":"Tepezza Lawsuit Update 2026: Payouts, News, Trials    LawFold.com","url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE5QYW1WRWFxUmRja0c3aS1NUzh0ai1STm8yN09DbzR3UmUyTlBHYi1pelZJa0k2QnhXeGlXMjFNa0MxQjZmV2lIUHprMzZ4R2NseWRqa1R3?oc=5","score":0.55,"decayed_score":null,"keywords":{"brands":["horizon therapeutics","amgen"],"products":["tepezza","teprotumumab","thyroid eye disease","hearing loss","tinnitus"]},"provenance":{"feed":"google_news_rss","published":"Sun, 12 Apr 2026 07:00:00 GMT","source_url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE5QYW1WRWFxUmRja0c3aS1NUzh0ai1STm8yN09DbzR3UmUyTlBHYi1pelZJa0k2QnhXeGlXMjFNa0MxQjZmV2lIUHprMzZ4R2NseWRqa1R3?oc=5","retrieved_at":"2026-07-16T08:12:19Z","search_query":"\"tepezza\" (lawsuit OR settlement OR recall OR \"class action\")"},"resolved_by":"auto","resolution_confidence":1.0,"first_seen_iso":"2026-07-07T10:24:49Z","last_seen_iso":"2026-07-16T08:12:19Z","schema_version":1},{"signal_id":"sig_3be3b1a6f9dc99","matter_id":"mat_ead13a2aadc579","source":"google_news","source_id":"gnews:CBMiZ0FVX3lxTE5UT3dkajRDUEZJMTREVF9EUi1UdGhob0l5a3BBdUR1eERsb09fZ0h0RVZscGVmY2RRNUJzWU9FRV9QdWFJMjR5MWZlS3JaT2UwaWdKR0xGeU14b3lnWENhT0Z4UEVOMDg","kind":"news_article","title":"Tepezza Hearing Loss Lawsuits - ClassAction.org","summary":"Tepezza Hearing Loss Lawsuits    ClassAction.org","url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE5UT3dkajRDUEZJMTREVF9EUi1UdGhob0l5a3BBdUR1eERsb09fZ0h0RVZscGVmY2RRNUJzWU9FRV9QdWFJMjR5MWZlS3JaT2UwaWdKR0xGeU14b3lnWENhT0Z4UEVOMDg?oc=5","score":0.55,"decayed_score":null,"keywords":{"brands":["horizon therapeutics","amgen"],"products":["tepezza","teprotumumab","thyroid eye disease","hearing loss","tinnitus"]},"provenance":{"feed":"google_news_rss","published":"Wed, 01 May 2024 07:00:00 GMT","source_url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE5UT3dkajRDUEZJMTREVF9EUi1UdGhob0l5a3BBdUR1eERsb09fZ0h0RVZscGVmY2RRNUJzWU9FRV9QdWFJMjR5MWZlS3JaT2UwaWdKR0xGeU14b3lnWENhT0Z4UEVOMDg?oc=5","retrieved_at":"2026-07-16T08:12:19Z","search_query":"\"tepezza\" (lawsuit OR settlement OR recall OR \"class action\")"},"resolved_by":"auto","resolution_confidence":1.0,"first_seen_iso":"2026-07-07T10:24:49Z","last_seen_iso":"2026-07-16T08:12:19Z","schema_version":1},{"signal_id":"sig_fb91dcde1b9a8b","matter_id":"mat_ead13a2aadc579","source":"google_news","source_id":"gnews:CBMirgFBVV95cUxPS0hRdzE0M2VpOGRlQjJrczM4T0VQME5PS2Zpd2xWZ0RBRmNHNmFoeFhVb2trZDRkSTA5T1VRdWhtRnl4Y3RxMEJpSVZKV09aX2NwMUNkdlZfWGhVd1BLM1hoTHNzSjVkWmQyNUVXT2twZnQ2TGp2ZVBTekMyaFJrcXlrVWltQWpRcDR3cUlmVW8weXc1WXYzR3h0X3Q3d1M2SnQ4ZTVRcDJwX2ItcVE","kind":"news_article","title":"Tepezza Liability Could be Acquired in Amgen-Horizon Merger - Medtruth","summary":"Tepezza Liability Could be Acquired in Amgen-Horizon Merger    Medtruth","url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPS0hRdzE0M2VpOGRlQjJrczM4T0VQME5PS2Zpd2xWZ0RBRmNHNmFoeFhVb2trZDRkSTA5T1VRdWhtRnl4Y3RxMEJpSVZKV09aX2NwMUNkdlZfWGhVd1BLM1hoTHNzSjVkWmQyNUVXT2twZnQ2TGp2ZVBTekMyaFJrcXlrVWltQWpRcDR3cUlmVW8weXc1WXYzR3h0X3Q3d1M2SnQ4ZTVRcDJwX2ItcVE?oc=5","score":0.55,"decayed_score":null,"keywords":{"brands":["horizon therapeutics","amgen"],"products":["tepezza","teprotumumab","thyroid eye disease","hearing loss","tinnitus"]},"provenance":{"feed":"google_news_rss","published":"Thu, 14 Sep 2023 07:00:00 GMT","source_url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPS0hRdzE0M2VpOGRlQjJrczM4T0VQME5PS2Zpd2xWZ0RBRmNHNmFoeFhVb2trZDRkSTA5T1VRdWhtRnl4Y3RxMEJpSVZKV09aX2NwMUNkdlZfWGhVd1BLM1hoTHNzSjVkWmQyNUVXT2twZnQ2TGp2ZVBTekMyaFJrcXlrVWltQWpRcDR3cUlmVW8weXc1WXYzR3h0X3Q3d1M2SnQ4ZTVRcDJwX2ItcVE?oc=5","retrieved_at":"2026-07-16T08:12:19Z","search_query":"\"tepezza\" (lawsuit OR settlement OR recall OR \"class action\")"},"resolved_by":"auto","resolution_confidence":1.0,"first_seen_iso":"2026-07-07T10:24:49Z","last_seen_iso":"2026-07-16T08:12:19Z","schema_version":1},{"signal_id":"sig_f83548d182cdc7","matter_id":"mat_ead13a2aadc579","source":"google_news","source_id":"gnews:CBMiyAFBVV95cUxQQkNlNjRzQ0tSX2E5bnBlR3FrUVVhVDZmUjU1enUxbENPeHFoYl9CN2pZTFdaYlVkOTBGbms1Rng2eVZBUWhWczhtZkNOVG9mY20tRkRrMXM5d1R2ZWNUVjJwZHpjT1NwRS0zVHI4NkxEN05EQXNMdmxkLUx3RmFIb251d3lPUUsyWTR6a21rUGs4M25KSUpYU01TY2traDJOam0tVlB4VnhhSVBFZ2ZZTWo1OF9aaW9feFJabU1zdElvenBrWlhqVQ","kind":"news_article","title":"Lawsuit alleges teprotumumab-trbw from Horizon Therapeutics caused permanent hearing loss - Ophthalmology Times Europe","summary":"Lawsuit alleges teprotumumab-trbw from Horizon Therapeutics caused permanent hearing loss    Ophthalmology Times Europe","url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxQQkNlNjRzQ0tSX2E5bnBlR3FrUVVhVDZmUjU1enUxbENPeHFoYl9CN2pZTFdaYlVkOTBGbms1Rng2eVZBUWhWczhtZkNOVG9mY20tRkRrMXM5d1R2ZWNUVjJwZHpjT1NwRS0zVHI4NkxEN05EQXNMdmxkLUx3RmFIb251d3lPUUsyWTR6a21rUGs4M25KSUpYU01TY2traDJOam0tVlB4VnhhSVBFZ2ZZTWo1OF9aaW9feFJabU1zdElvenBrWlhqVQ?oc=5","score":0.55,"decayed_score":null,"keywords":{"brands":["horizon therapeutics","amgen"],"products":["tepezza","teprotumumab","thyroid eye disease","hearing loss","tinnitus"]},"provenance":{"feed":"google_news_rss","published":"Wed, 19 Apr 2023 07:00:00 GMT","source_url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxQQkNlNjRzQ0tSX2E5bnBlR3FrUVVhVDZmUjU1enUxbENPeHFoYl9CN2pZTFdaYlVkOTBGbms1Rng2eVZBUWhWczhtZkNOVG9mY20tRkRrMXM5d1R2ZWNUVjJwZHpjT1NwRS0zVHI4NkxEN05EQXNMdmxkLUx3RmFIb251d3lPUUsyWTR6a21rUGs4M25KSUpYU01TY2traDJOam0tVlB4VnhhSVBFZ2ZZTWo1OF9aaW9feFJabU1zdElvenBrWlhqVQ?oc=5","retrieved_at":"2026-07-13T09:25:18Z","search_query":"\"tepezza\" (lawsuit OR settlement OR recall OR \"class action\")"},"resolved_by":"auto","resolution_confidence":0.50625,"first_seen_iso":"2026-07-07T10:24:49Z","last_seen_iso":"2026-07-13T09:25:18Z","schema_version":1},{"signal_id":"sig_08da5dd940d04d","matter_id":"mat_ead13a2aadc579","source":"google_news","source_id":"gnews:CBMihgFBVV95cUxNVTNYSDdnRlpEZ3hxTHM3bFUtck93V2o0LTFZV0lLUTVHNXNON2RyTTN1LUJBS0dXXzhHdFNKX2hVMnVlM2RsQmd4TFlGS0szTWI5bnIxeDJHNmhQb1llT0JoQXV6MjhwZnU4dEF5T3hMWnlCc1lmQVhINVp2WVRjUzhWMUxzdw","kind":"news_article","title":"Tepezza Hearing Loss Trial Date Pushed Back to Aug. 2026 - AboutLawsuits.com","summary":"Tepezza Hearing Loss Trial Date Pushed Back to Aug. 2026    AboutLawsuits.com","url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNVTNYSDdnRlpEZ3hxTHM3bFUtck93V2o0LTFZV0lLUTVHNXNON2RyTTN1LUJBS0dXXzhHdFNKX2hVMnVlM2RsQmd4TFlGS0szTWI5bnIxeDJHNmhQb1llT0JoQXV6MjhwZnU4dEF5T3hMWnlCc1lmQVhINVp2WVRjUzhWMUxzdw?oc=5","score":0.55,"decayed_score":null,"keywords":{"brands":["horizon therapeutics","amgen"],"products":["tepezza","teprotumumab","thyroid eye disease","hearing loss","tinnitus"]},"provenance":{"feed":"google_news_rss","published":"Wed, 27 Aug 2025 07:00:00 GMT","source_url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNVTNYSDdnRlpEZ3hxTHM3bFUtck93V2o0LTFZV0lLUTVHNXNON2RyTTN1LUJBS0dXXzhHdFNKX2hVMnVlM2RsQmd4TFlGS0szTWI5bnIxeDJHNmhQb1llT0JoQXV6MjhwZnU4dEF5T3hMWnlCc1lmQVhINVp2WVRjUzhWMUxzdw?oc=5","retrieved_at":"2026-07-16T08:12:19Z","search_query":"\"tepezza\" (lawsuit OR settlement OR recall OR \"class action\")"},"resolved_by":"auto","resolution_confidence":1.0,"first_seen_iso":"2026-07-07T10:24:49Z","last_seen_iso":"2026-07-16T08:12:19Z","schema_version":1},{"signal_id":"sig_f1fbbb4729294f","matter_id":"mat_ead13a2aadc579","source":"google_news","source_id":"gnews:CBMiT0FVX3lxTE1BOW12eWJsNzROaFNGTHBFNC1SZjZjdlAybURGZmdHaGNVV2dzTWFkYnNmZFYtU0MtdzZhek1CR3E1UGl1RDlkWlEwLTIxaW8","kind":"news_article","title":"Tepezza Hearing Loss Lawsuit Settlement Information - April 2026 - AboutLawsuits.com","summary":"Tepezza Hearing Loss Lawsuit Settlement Information - April 2026    AboutLawsuits.com","url":"https://news.google.com/rss/articles/CBMiT0FVX3lxTE1BOW12eWJsNzROaFNGTHBFNC1SZjZjdlAybURGZmdHaGNVV2dzTWFkYnNmZFYtU0MtdzZhek1CR3E1UGl1RDlkWlEwLTIxaW8?oc=5","score":0.55,"decayed_score":null,"keywords":{"brands":["horizon therapeutics","amgen"],"products":["tepezza","teprotumumab","thyroid eye disease","hearing loss","tinnitus"]},"provenance":{"feed":"google_news_rss","published":"Fri, 05 Jun 2026 07:00:00 GMT","source_url":"https://news.google.com/rss/articles/CBMiT0FVX3lxTE1BOW12eWJsNzROaFNGTHBFNC1SZjZjdlAybURGZmdHaGNVV2dzTWFkYnNmZFYtU0MtdzZhek1CR3E1UGl1RDlkWlEwLTIxaW8?oc=5","retrieved_at":"2026-07-15T08:08:53Z","search_query":"\"tepezza\" (lawsuit OR settlement OR recall OR \"class action\")"},"resolved_by":"auto","resolution_confidence":1.0,"first_seen_iso":"2026-07-07T10:24:49Z","last_seen_iso":"2026-07-15T08:08:53Z","schema_version":1}]},"meta":{"api_version":"v1","schema_version":1,"self":"https://www.getclaimscout.com/api/v1/matters/tepezza-hearing-loss","docs":"https://getclaimscout.com/openapi.json","llms_txt":"https://getclaimscout.com/llms.txt"}}